Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,600
  • Shares Outstanding, K 21,200
  • Annual Sales, $ 220 K
  • Annual Income, $ -14,310 K
  • 36-Month Beta 1.15
  • Price/Sales 55.23
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/08/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.13
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.22 unch
on 09/21/18
0.84 -74.29%
on 09/10/18
-0.54 (-71.39%)
since 08/21/18
3-Month
0.22 unch
on 09/21/18
1.10 -80.36%
on 07/02/18
-0.87 (-80.18%)
since 06/21/18
52-Week
0.22 unch
on 09/21/18
2.85 -92.42%
on 10/26/17
-1.38 (-86.50%)
since 09/21/17

Most Recent Stories

More News
Titan Pharmaceuticals Prices $9,500,000 Public Offering

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company"), a commercial stage company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM)...

TTNP : 0.22 (-56.00%)
Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that it has been awarded a two year grant of approximately $6.7 million from the National Institutes of Health's National Institute on Drug Abuse...

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals: 2Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Tuesday reported a loss of $869,000 in its second quarter.

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals Reports Second Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.22 (-56.00%)
Titan Announces Amendment To Agreement With Molteni

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that it has entered into an amendment (the "Amendment") of the previously announced definitive asset purchase, supply and support agreement (the...

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals Provides Update On Parkinson's Disease Clinical Development Program

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals: 1Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Tuesday reported a loss of $2.6 million in its first quarter.

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals Reports First Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.22 (-56.00%)
Titan Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 2, 2018 / Titan Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 2, 2018 at 4:15 PM Eastern Time....

TTNP : 0.22 (-56.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TTNP with:

Business Summary

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical...

See More

Key Turning Points

2nd Resistance Point 0.63
1st Resistance Point 0.57
Last Price 0.22
1st Support Level 0.47
2nd Support Level 0.43

See More

52-Week High 2.85
Fibonacci 61.8% 1.84
Fibonacci 50% 1.53
Fibonacci 38.2% 1.22
Last Price 0.22
52-Week Low 0.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar